|
ZNF391 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.243500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.522900000003E-05 |
| Normal-vs-Stage2 |
2.182200E-01 |
| Normal-vs-Stage3 |
5.640800E-01 |
| Normal-vs-Stage4 |
5.143200E-01 |
| Stage1-vs-Stage2 |
4.571400E-01 |
| Stage1-vs-Stage3 |
8.173800E-02 |
| Stage1-vs-Stage4 |
6.933200E-01 |
| Stage2-vs-Stage3 |
5.570200E-01 |
| Stage2-vs-Stage4 |
9.829000E-01 |
| Stage3-vs-Stage4 |
6.853200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.189400E-04 |
| Normal-vs-AfricanAmerican |
3.728100E-02 |
| Normal-vs-Asian |
1.764210E-01 |
| Caucasian-vs-AfricanAmerican |
5.662400E-01 |
| Caucasian-vs-Asian |
6.577200E-01 |
| AfricanAmerican-vs-Asian |
5.044600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.155600E-04 |
| Normal-vs-Female |
1.368360E-01 |
| Male-vs-Female |
1.175810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.342350E-02 |
| Normal-vs-Extreme_Weight |
1.80419999999959E-05 |
| Normal-vs-Obese |
2.014000E-01 |
| Normal-vs-Extreme_Obese |
2.182100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.486400E-01 |
| Normal_Weight-vs-Obese |
3.595600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.991600E-01 |
| Extreme_Weight-vs-Obese |
2.548300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.462200E-01 |
| Obese-vs-Extreme_Obese |
2.284600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.242600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.676780E-01 |
| Normal-vs-Age(61-80Yrs) |
4.70249999995342E-06 |
| Normal-vs-Age(81-100Yrs) |
1.647570E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.979200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.094400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.372200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.443100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.937570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.446600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.235200E-04 |
| Normal-VS-Type2 PRCC |
4.517300E-03 |
| Normal-VS-KIRP CIMP |
2.125600E-01 |
| Normal-VS-Unclassified PRCC |
8.595000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.714800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.794800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.354840E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.634400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.097980E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.229200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.27589999998623E-06 |
| Normal-vs-N1 |
8.190000E-01 |
| Normal-vs-N2 |
1.278610E-03 |
| N0-vs-N1 |
1.759710E-02 |
| N0-vs-N2 |
5.191000E-01 |
| N1-vs-N2 |
1.834210E-01 |
|
|
